Estimated reading time: 2 minute(s)
Nvsted, St. Louis’ first regulation crowdfunding portal, continues to add hyperlocal company crowdfunding campaigns to its platform following the success of their first crowdfunding campaign which raised nearly $200,000 for Wellbeing Brewing; helping the company expand into major retailers Whole Foods, Total Wine, Target, and UK online retailer, DryDrinker. To kick off 2019 Nvsted launched two new investment campaigns.
One is for CAD Trailer Designs, a company which invented a patented folding trailer for home and business use. The other is biotech startup Pluton Biosciences, who may have developed an environmentally sustainable way to reduce the spread of infectious diseases carried by mosquitos.
h2>CAD Trailer Designs
CAD Trailer Designs manufactures and distributes a patented foldable utility trailer to recreational and business consumers in untapped urban/suburban markets. These trailers are designed to fold simply and fit compactly inside a garage while allowing enough space to park a car, thus solving the problem of parking the trailer on the street or in a driveway (which is restricted in many communities).
The team at CAD TD launched their crowdfunding campaign on January 31 and is open for investments starting at $500.
“This trailer not only redefines the trailer industry, it truly transforms your life,” said Russ Davis, CEO of CAD TD. Davis’ team mates, Andrew Cannon (CFO) and Joe McKeever (COO), had been corporate executives for years in the utility trailer industry but joined CAD TD when they recognized the need for innovation.
The manufacturing of the trailers will take place in St. Louis, and the unique design allows for significantly reduced shipping costs, both nationally and internationally.
Pluton discovers, “new microbes for development into sustainable bio-solutions.” To put that in simpler terms, the company recently discovered a larvicidal method of killing mosquitos, which could be deployed as a way to mitigate the spread of the Zika virus, Dengue or Yellow Fever.
“Pluton Biosciences aspires to solve global problems by discovering natural, beneficial microbes already living in the soil,” said CEO Charlie Walch.
Pluton’s funding campaign is open for investments as small as $1000. The company has raised $14,500 since the campaign launched on January 11.
“By partnering with global producers to create natural bioproducts for a variety of industries, we can help ensure a sustainable future for our planet. We are very excited to tell our story through the Nvsted platform and to support our hometown’s aspiration to become a destination city for life science startups and entrepreneurs.”
“Nvsted, and St. Louis’ various entrepreneurial support organizations are making our region an attractive destination for a number of companies making breakthroughs in the areas of human health, plant science, and AgTech,” said Janet Wilding, Vice President of Major Projects and 39 North at SLEDP. “The St. Louis region continues to grow as a hub for groundbreaking work in the biotech industry.”